Akebia Therapeutics Inc
NASDAQ:AKBA
Income Statement
Earnings Waterfall
Akebia Therapeutics Inc
Revenue
|
194.6m
USD
|
Cost of Revenue
|
-39.7m
USD
|
Gross Profit
|
154.9m
USD
|
Operating Expenses
|
-199.4m
USD
|
Operating Income
|
-44.5m
USD
|
Other Expenses
|
-7.5m
USD
|
Net Income
|
-51.9m
USD
|
Income Statement
Akebia Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
22
+1 393%
|
51
+127%
|
92
+81%
|
181
+97%
|
206
+14%
|
227
+10%
|
239
+5%
|
208
-13%
|
235
+13%
|
287
+22%
|
325
+14%
|
335
+3%
|
351
+5%
|
340
-3%
|
308
-9%
|
295
-4%
|
258
-12%
|
221
-14%
|
210
-5%
|
212
+1%
|
221
+4%
|
295
+33%
|
294
0%
|
293
-1%
|
270
-8%
|
200
-26%
|
194
-3%
|
195
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(29)
|
(59)
|
(89)
|
(113)
|
(109)
|
(130)
|
(125)
|
(132)
|
(160)
|
(153)
|
(136)
|
(103)
|
(116)
|
(82)
|
(104)
|
(23)
|
(42)
|
(40)
|
(20)
|
(40)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
181
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
201
N/A
|
103
-49%
|
175
+69%
|
237
+35%
|
223
-6%
|
242
+9%
|
210
-13%
|
183
-13%
|
162
-11%
|
99
-39%
|
68
-31%
|
74
+9%
|
109
+47%
|
105
-3%
|
213
+102%
|
190
-10%
|
270
+42%
|
228
-15%
|
160
-30%
|
173
+8%
|
155
-11%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(16)
|
(23)
|
(28)
|
(34)
|
(38)
|
(39)
|
(42)
|
(52)
|
(62)
|
(77)
|
(102)
|
(119)
|
(138)
|
(178)
|
(192)
|
(222)
|
(258)
|
(263)
|
(296)
|
(312)
|
(380)
|
(435)
|
(481)
|
(518)
|
(509)
|
(511)
|
(478)
|
(453)
|
(405)
|
(482)
|
(358)
|
(361)
|
(358)
|
(365)
|
(344)
|
(317)
|
(305)
|
(262)
|
(251)
|
(228)
|
(199)
|
|
Selling, General & Administrative |
(5)
|
(8)
|
(10)
|
(12)
|
(13)
|
(12)
|
(14)
|
(15)
|
(19)
|
(21)
|
(23)
|
(24)
|
(22)
|
(22)
|
(24)
|
(26)
|
(27)
|
(30)
|
(36)
|
(40)
|
(87)
|
(112)
|
(136)
|
(160)
|
(150)
|
(153)
|
(153)
|
(159)
|
(154)
|
(158)
|
(164)
|
(170)
|
(174)
|
(178)
|
(168)
|
(154)
|
(139)
|
(120)
|
(115)
|
(105)
|
(100)
|
|
Research & Development |
(11)
|
(15)
|
(18)
|
(22)
|
(25)
|
(27)
|
(28)
|
(38)
|
(43)
|
(56)
|
(79)
|
(95)
|
(116)
|
(156)
|
(168)
|
(196)
|
(231)
|
(232)
|
(260)
|
(272)
|
(291)
|
(312)
|
(326)
|
(330)
|
(323)
|
(322)
|
(289)
|
(261)
|
(219)
|
(178)
|
(162)
|
(156)
|
(148)
|
(151)
|
(140)
|
(127)
|
(130)
|
(107)
|
(101)
|
(86)
|
(63)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(11)
|
(20)
|
(29)
|
(36)
|
(36)
|
(36)
|
(33)
|
(33)
|
(33)
|
(32)
|
(35)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(114)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(16)
N/A
|
(23)
-46%
|
(28)
-20%
|
(34)
-20%
|
(38)
-13%
|
(39)
-3%
|
(42)
-8%
|
(52)
-24%
|
(62)
-18%
|
(77)
-25%
|
(102)
-33%
|
(119)
-16%
|
(137)
-15%
|
(155)
-14%
|
(141)
+9%
|
(129)
+8%
|
(77)
+41%
|
(56)
+27%
|
(70)
-24%
|
(73)
-5%
|
(178)
-143%
|
(230)
-29%
|
(254)
-10%
|
(282)
-11%
|
(286)
-2%
|
(269)
+6%
|
(268)
+0%
|
(270)
-1%
|
(243)
+10%
|
(384)
-58%
|
(290)
+24%
|
(287)
+1%
|
(250)
+13%
|
(259)
-4%
|
(131)
+49%
|
(127)
+4%
|
(35)
+73%
|
(34)
+2%
|
(92)
-170%
|
(54)
+41%
|
(44)
+18%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
5
|
6
|
6
|
5
|
3
|
1
|
(2)
|
(5)
|
(7)
|
(9)
|
(12)
|
(14)
|
(17)
|
(20)
|
(20)
|
(20)
|
(19)
|
(16)
|
(12)
|
(9)
|
(6)
|
(6)
|
|
Non-Reccuring Items |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(116)
|
(116)
|
(135)
|
0
|
1
|
1
|
(15)
|
0
|
(15)
|
(16)
|
(47)
|
(17)
|
(3)
|
(2)
|
(2)
|
|
Total Other Income |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
1
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
|
Pre-Tax Income |
(13)
N/A
|
(22)
-69%
|
(27)
-22%
|
(33)
-20%
|
(37)
-14%
|
(38)
-3%
|
(41)
-8%
|
(51)
-25%
|
(61)
-18%
|
(76)
-25%
|
(101)
-33%
|
(118)
-17%
|
(136)
-15%
|
(155)
-14%
|
(140)
+9%
|
(127)
+9%
|
(74)
+42%
|
(53)
+29%
|
(65)
-24%
|
(68)
-4%
|
(172)
-153%
|
(224)
-30%
|
(249)
-11%
|
(279)
-12%
|
(286)
-3%
|
(272)
+5%
|
(389)
-43%
|
(393)
-1%
|
(385)
+2%
|
(394)
-2%
|
(301)
+24%
|
(301)
+0%
|
(282)
+6%
|
(276)
+2%
|
(164)
+41%
|
(158)
+3%
|
(94)
+40%
|
(61)
+35%
|
(101)
-67%
|
(62)
+39%
|
(52)
+16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
28
|
31
|
32
|
33
|
7
|
4
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(13)
|
(22)
|
(27)
|
(33)
|
(37)
|
(38)
|
(41)
|
(51)
|
(61)
|
(76)
|
(101)
|
(118)
|
(136)
|
(155)
|
(140)
|
(127)
|
(74)
|
(53)
|
(65)
|
(68)
|
(144)
|
(193)
|
(217)
|
(245)
|
(280)
|
(268)
|
(386)
|
(391)
|
(385)
|
(394)
|
(301)
|
(301)
|
(282)
|
(276)
|
(164)
|
(158)
|
(94)
|
(61)
|
(101)
|
(62)
|
(52)
|
|
Net Income (Common) |
(69)
N/A
|
(164)
-138%
|
(120)
+27%
|
(123)
-2%
|
(124)
-1%
|
(38)
+69%
|
(41)
-8%
|
(51)
-25%
|
(61)
-18%
|
(76)
-25%
|
(101)
-33%
|
(118)
-17%
|
(136)
-15%
|
(155)
-14%
|
(140)
+9%
|
(127)
+9%
|
(74)
+42%
|
(53)
+29%
|
(65)
-24%
|
(68)
-4%
|
(144)
-111%
|
(193)
-34%
|
(217)
-13%
|
(245)
-13%
|
(280)
-14%
|
(268)
+4%
|
(386)
-44%
|
(391)
-1%
|
(385)
+2%
|
(394)
-2%
|
(301)
+24%
|
(301)
+0%
|
(282)
+6%
|
(276)
+2%
|
(164)
+41%
|
(158)
+3%
|
(94)
+40%
|
(61)
+35%
|
(101)
-67%
|
(62)
+39%
|
(52)
+16%
|
|
EPS (Diluted) |
-3.78
N/A
|
-74.63
-1 874%
|
-3.78
+95%
|
-6.21
-64%
|
-8.04
-29%
|
-1.9
+76%
|
-1.54
+19%
|
-1.78
-16%
|
-2.29
-29%
|
-2.05
+10%
|
-2.67
-30%
|
-3.1
-16%
|
-3.6
-16%
|
-3.98
-11%
|
-3.43
+14%
|
-2.7
+21%
|
-1.69
+37%
|
-1.08
+36%
|
-1.14
-6%
|
-1.21
-6%
|
-2.47
-104%
|
-1.64
+34%
|
-1.83
-12%
|
-2.06
-13%
|
-2.36
-15%
|
-2.08
+12%
|
-2.81
-35%
|
-2.72
+3%
|
-2.78
-2%
|
-2.56
+8%
|
-1.86
+27%
|
-1.72
+8%
|
-1.7
+1%
|
-1.51
+11%
|
-0.85
+44%
|
-0.85
N/A
|
-0.52
+39%
|
-0.33
+37%
|
-0.54
-64%
|
-0.33
+39%
|
-0.28
+15%
|